alexa An Overview of New Delhi Metallo-Beta Lactamase-1 and Extended Spectrum Beta Lactamase Producing Bacteria: Need for an Alternate | OMICS International| Abstract
ISSN: 2472-1212

Journal of Antimicrobial Agents
Open Access

Like us on:

Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)
  • Review Article   
  • J Antimicrob Agents 2018, Vol 4(1): 155
  • DOI: 10.4172/2472-1212.1000155

An Overview of New Delhi Metallo-Beta Lactamase-1 and Extended Spectrum Beta Lactamase Producing Bacteria: Need for an Alternate

Bhattacharya D*, Chandar B and Dwibedi GR
Department of Health Research, ICMR-Regional Medical Research Centre, , Bhubaneswar, India
*Corresponding Author : Bhattacharya D, Scientist-C/Sr. Research Officer, ICMR-Regional Medical Research Centre, Dept. of Health Research, Govt. of India, Chandrasekharpur-751023, Bhubaneswar, India, Tel: +91-674-2305655, Email: [email protected]

Received Date: Dec 05, 2017 / Accepted Date: Jan 11, 2018 / Published Date: Jan 12, 2018


Resistance to antibiotics is increasing dangerously worldwide. The emergence of antibiotic resistant bacteria is no more a local problem and calls for global action. It has become a leading challenge in infectious diseases management. The effectiveness of current drugs is restricted by emergence of multi-drug resistant bacterial strains and they have become the major reason for treatment failure of infections. Antimicrobial agents were initially highly successful in treating infections; however, their unsound use leads to rise in antimicrobial resistance frighteningly, especially in the developing countries. With the emergence of New Delhi Metallo-beta lactamase-1 and Extended Spectrum Beta Lactamase producing bacteria the clinicians are left with a very limited choice of treating the common infections. The recent situation calls for an urgent need for search of alternatives like herbal medicine which has shown potential in treating various other ailments. Because herbs are plants, they are often perceived as “natural” and therefore safe. Development of plant based compounds and combinational therapies using compounds may provide safer options for the community. Research should focus on scrutinizing compounds from plants for a target and bioactivity based drug discovery. However, the safety of using most herbs with drugs is not well established. Some herbs are known to interact with pharmaceutical drugs, although most of this information comes from case reports rather than systematic investigations. Because many herbs contain pharmacologically active compounds, some herbs may cause side effects through excessive biological effects. Unfortunately, the true frequency of side effects for most herbs is not known because most have not been tested in large clinical trials and because surveillance systems are much less extensive than those in place for pharmaceutical products. There is also a need for a strict regulations and policy in place for the use of herbal drugs or compounds of herbal origin in treatment of various common bacterial infections.

Keywords: Multi-drug resistance, NDM-1, ESBL, Herbal drugs

Citation: Bhattacharya D, Chandar B, Dwibedi GR (2018) An Overview of New Delhi Metallo-Beta Lactamase-1 and Extended Spectrum Beta Lactamase Producing Bacteria: Need for an Alternate. J Antimicrob Agents 4:155. Doi: 10.4172/2472-1212.1000155

Copyright: © 2018 Bhattacharya D, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Select your language of interest to view the total content in your interested language

Post Your Comment Citation
Share This Article
Recommended Conferences
  • 4th International Conference on Medical & Clinical Microbiology

    March 18-19, 2020 | Singapore City, Singapore

  • 9th Annual Congress on Clinical Microbiology and Infectious Diseases

    MARCH 27-28, 2020 Barcelona, Spain

  • 5th World Conference on Applied Microbiology and Beneficial Microbes

    April 27-28, 2020 Singapore City, Singapore

Article Usage
  • Total views: 1486
  • [From(publication date): 0-2018 - Dec 09, 2019]
  • Breakdown by view type
  • HTML page views: 1400
  • PDF downloads: 86